VERTEX PHARMACEUTICALS INC / MA (VRTX) revenue & profit
VERTEX PHARMACEUTICALS INC / MA (VRTX): revenue $12B, net income $4B in 2025; latest quarter +12.5% year over year. From SEC filings.
$12BRevenue 2025
TickerVRTX (Nasdaq)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$12B
Net income 2025$4B
Net margin32.9%
Annual revenue growth+8.9%
Latest quarter (2026 Q2) · Revenue$3.3B
vs. same quarter last year+12.5%
Latest quarter · Net income$1.1B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $8.9B | $3.3B | |
| 2023 | $9.9B | $3.6B | |
| 2024 | $11B | -$535.6M | |
| 2025 | $12B | $4B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.